Abuse-Deterrent Opioids

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1522期
关键词：
EXTENDED-RELEASE OXYCODONE; FORMULATION; OXYCONTIN;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [31] Non-Analgesic Effects of Opioids: Factors Relevant to Opioid Abuse and Abuse-Deterrent Formulations
    Pergolizzi, Joseph V., Jr.
    Raffa, Robert B.
    Pergolizzi, Jason S.
    Taylor, Robert, Jr.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (37) : 6109 - 6115
  • [32] Abuse-Deterrent Opioid Formulations
    Abramowicz, Mark
    Zuccotti, Gianna
    Pflomm, Jean-Marie
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (16): : 1744 - 1745
  • [33] Abuse-deterrent Opioid Formulations
    Litman, Ronald S.
    Pagan, Olivia H.
    Cicero, Theodore J.
    [J]. ANESTHESIOLOGY, 2018, 128 (05) : 1015 - 1026
  • [34] Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin
    Beheshti, David
    [J]. HEALTH ECONOMICS, 2019, 28 (12) : 1449 - 1461
  • [35] Abuse-Deterrent Opioid Formulations
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1476): : 119 - 121
  • [36] Human abuse potential studies of abuse-deterrent opioids: lessons from oral and intranasal studies with morphine abuse-deterrent, extended-release, injection-molded tablets
    Webster, Lynn R.
    Viscusi, Eugene R.
    Brown, Colville
    Dayno, Jeffrey M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 893 - 901
  • [37] Reducing extramedical use and harms of pharmaceutical opioids: the potential role of abuse-deterrent formulations
    Degenhardt, Louisa
    Larance, Briony
    Peacock, Amy
    Farrell, Michael
    [J]. Lancet Psychiatry, 2015, 2 (11): : 957 - 959
  • [38] Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?
    Kaddis, Atheer A.
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (01): : 30 - 31
  • [39] Abuse-Deterrent OxyContin And Hepatitis C
    Bigal, Marcelo E.
    [J]. HEALTH AFFAIRS, 2019, 38 (04)
  • [40] Effect of Abuse-Deterrent Formulation of OxyContin
    Cicero, Theodore J.
    Ellis, Matthew S.
    Surratt, Hilary L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 187 - 189
12345